Intelerad Launches New Imaging Software Suite at HIMSS 2022
Offering a potential antidote to health-care silos that can hamper and delay care, the Enterprise Imaging and Informatics Suite may revamp image sharing and communication between providers.
Offering the promise of secure image sharing, improved workflow efficiencies and enhanced integration with electronic health records (EHRs) and referring provider portals, a new software suite may provide radiologists with an emerging option for medical image management.
Seeking to develop an integrated hub with centralized patient data, Intelerad Medical Systems has launched the Enterprise Imaging and Informatics Suite at the 2022 Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition in Orlando, Fla.
Incorporating components from acquired brands ranging from Ambra Health to HeartIT, the Enterprise Imaging and Informatics Suite reportedly facilitates improved interoperability, greater efficiency, and improved communication between providers, according to Intelerad.
“Intelerad’s Enterprise Imaging and Informatics Suite provides hospitals and health systems with an industry-leading enterprise imaging solution,” noted Mike Lipps, the chief executive office for Intelerad. “As demand for managing, sharing and analyzing patient data and images continues to grow, health-care customers need a powerful, scalable, vendor-neutral imaging system that improves overall performance.”
Intelerad says key components of the software suite, among others, include:
• the Clario SmartWorklist™, which enables radiologists to efficiently manage imaging and patient data in one place;
• Ambra Image Exchange, which enhances collaboration between providers through secure transmission of patent images; and
• the Cardiovascular Suite, which features registry alignment, analytics reports and EHR integration.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.
